ID: ALA4761465

Max Phase: Preclinical

Molecular Formula: C16H12N4O3

Molecular Weight: 308.30

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cccc([N+](=O)[O-])c1)Nc1ccc2cccnc2c1

Standard InChI:  InChI=1S/C16H12N4O3/c21-16(18-12-4-1-5-14(9-12)20(22)23)19-13-7-6-11-3-2-8-17-15(11)10-13/h1-10H,(H2,18,19,21)

Standard InChI Key:  YGGGFAQVXHMPDF-UHFFFAOYSA-N

Associated Targets(Human)

Bromodomain adjacent to zinc finger domain protein 1A 48 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.30Molecular Weight (Monoisotopic): 308.0909AlogP: 3.79#Rotatable Bonds: 3
Polar Surface Area: 97.16Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.06CX Basic pKa: 4.04CX LogP: 3.22CX LogD: 3.22
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: -1.80

References

1. Yang Z,Zhou Y,Zhong L.  (2021)  Discovery of BAZ1A bromodomain inhibitors with the aid of virtual screening and activity evaluation.,  33  [PMID:33333161] [10.1016/j.bmcl.2020.127745]

Source